Literature DB >> 6978891

T lymphocyte interaction with immunoglobulin G antibody in systemic lupus erythematosus.

K Okudaira, R P Searles, K Tanimoto, Y Horiuchi, R C Williams.   

Abstract

Systemic lupus erythematosus (SLE) is an autoimmune disease with multiple immune disturbances whose mechanisms remain unclear. We examined the interaction of antilymphocyte antibodies with cultured normal T lymphocytes. T cells were prepared by E-rosetting after petri-dish removal of adherent cells and cultured for 2-7 d in the presence of SLE sera or normal human sera. Cultured T cells were washed and sonicated, and the amount of cell-associated IgG was quantitated by radioimmunoassay or enzyme-linked immunoassay (ELISA) methods. T cells cultured with 27 of 39 SLE sera showed marked increments of associated immunoglobulin G (IgG) although this was not observed with sera from mixed connective tissue disease patients containing high titers of ribonucleoprotein antibody or normal donors. The effective factors for IgG association in SLE sera were absorbed with normal peripheral blood lymphocytes or T cells. Anti-T cell IgG cytotoxic activity strongly correlated with T cell IgG association (P less than 0.01). T cell-associated IgG was not removed by stripping of cell membrane IgG from living cells by acid buffer treatment; indirect immunofluorescence of cells fixed after 2-4 d of culture revealed cytoplasmic IgG staining. IgG anti-T cell antibodies appeared to associate inside the cell membrane or to penetrate into the cytoplasm of cells. T cell Fc receptor blocking by heat-aggregated IgG or anti-beta 2-microglobulin antibody did not alter IgG cell association. Since pepsin-digested SLE sera showed no T cell association activity, whole IgG antibody molecules appeared to be necessary for interaction with cultured T cells. In addition, reduction and alkylation of active SLE sera completely nullified T cell reactivity. When normal T cells were cultured with SLE sera showing marked IgG T cell association, viability of cultured T cells decreased rapidly after 4 d, which suggests that IgG anti-T cell antibodies were associated with cell destruction. IgG cell-associating antilymphocyte antibodies present in SLE sera may cause T cell disturbances in vivo and may be related to the lymphocytopenia present in SLE patients.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6978891      PMCID: PMC370158          DOI: 10.1172/jci110506

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  32 in total

1.  A relationship between impaired cellular immunity humoral suppression of lymphocyte function and severity of systemic lupus erythematosus.

Authors:  D A Horwitz; J B Cousar
Journal:  Am J Med       Date:  1975-06       Impact factor: 4.965

2.  Antibody-dependent cell-mediated cytotoxicity in selected autoimmune diseases.

Authors:  J L Feldmann; M J Becker; H Moutsopoulos; K Fye; M Blackman; W V Epstein; N Talal
Journal:  J Clin Invest       Date:  1976-07       Impact factor: 14.808

3.  Inhibition of mixed leukocyte culture responses by serum and gamma-globulin fractions from certain patients with connective tissue disorders.

Authors:  R C Williams; R B Lies; R P Messner
Journal:  Arthritis Rheum       Date:  1973 Sep-Oct

4.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

5.  Direct lysis of lymphocytes by complement in patients with systemic lupus erythematosus.

Authors:  P Stastny; M Ziff
Journal:  Arthritis Rheum       Date:  1971 Nov-Dec

6.  Antibody-mediated lymphocytotoxicity in rheumatoid arthritis and systemic lupus erythematosus.

Authors:  E Diaz-Jouanen; A D Bankhurst; R C Williams
Journal:  Arthritis Rheum       Date:  1976 Mar-Apr

7.  Association of cold-reactive antilymphocyte antibodies with lymphopenia in systemic lupus erythematosus.

Authors:  J B Winfield; R J Winchester; H G Kunkel
Journal:  Arthritis Rheum       Date:  1975 Nov-Dec

8.  Serum and synovial fluid inhibitors of antibody-mediated lymphocytotoxicity in rheumatoid arthritis and systemic lupus erythematosus.

Authors: 
Journal:  Arthritis Rheum       Date:  1976 Mar-Apr

9.  Nature of cold-reactive antibodies to lymphocyte surface determinants in systemic lupus erythematosus.

Authors:  J B Winfield; R J Winchester; P Wernet; S M Fu; H G Kunkel
Journal:  Arthritis Rheum       Date:  1975 Jan-Feb

10.  Antibodies to a specific surface antigen of T cells in human sera inhibiting mixed leukocyte culture reactions.

Authors:  P Wernet; H G Kunkel
Journal:  J Exp Med       Date:  1973-10-01       Impact factor: 14.307

View more
  6 in total

1.  Autoantibodies to the heat-shock protein hsp90 in systemic lupus erythematosus.

Authors:  S Minota; S Koyasu; I Yahara; J Winfield
Journal:  J Clin Invest       Date:  1988-01       Impact factor: 14.808

2.  Molecular and structural analysis of nuclear localizing anti-DNA lupus antibodies.

Authors:  M H Foster; T Kieber-Emmons; M Ohliger; M P Madaio
Journal:  Immunol Res       Date:  1994       Impact factor: 2.829

Review 3.  Lymphocytotoxic antibodies in SLE: a review of the literature.

Authors:  C Osman; A J Swaak
Journal:  Clin Rheumatol       Date:  1994-03       Impact factor: 2.980

4.  Characterization of a factor in leprosy serum that inhibits the growth of mitogen-stimulated normal human lymphocytes.

Authors:  M A Kerr; Y M Hussein; R C Potts; J S Beck; M M Sheriff
Journal:  Immunology       Date:  1987-06       Impact factor: 7.397

5.  Inhibition of soluble antigen-induced T cell proliferation by warm-reactive antibodies to activated T cells in systemic lupus erythematosus.

Authors:  A Yamada; J B Winfield
Journal:  J Clin Invest       Date:  1984-12       Impact factor: 14.808

6.  Defective expression of the 2H4 molecule after autologous mixed lymphocyte reaction activation in systemic lupus erythematosus patients.

Authors:  T Takeuchi; S Tanaka; A D Steinberg; T Matsuyama; J Daley; S F Schlossman; C Morimoto
Journal:  J Clin Invest       Date:  1988-10       Impact factor: 14.808

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.